Point Of Care Technologies For Veterinary And Human Clinical Diagnostics
Test&Treat Limited was formed in 2017 to develop and commercialise point of care (PoC) tests for the rapid detection of urinary tract infections and subsequent antibiotic sensitivity (AS) analysis in veterinary and human clinical applications.
Utilising Test&Treat’s patented technology we have just begun to market the World’s first rapid (less than 1 hour) UTI detection and AS test into the veterinary market for use on companion animals. The same test can also be used for detection and antibiotic susceptibility of human UTI’s. Test&Treat is actively seeking diagnostic partners to license the technology for application to the human market.
UTI is one of the most prevalent infections presenting to doctors and veterinarians. The current T&T UTI test is designed to detect microbial urinary tract infections in companion animals (dogs and cats) in 5 minutes. The subsequent AS test (which takes 45 minutes) will then determine the quantitative antibiotic sensitivity of that infection. The results of the two tests allow the doctor or veterinarian to prescribe the most effective antibiotic for the detected infection and therefore provide an optimum rapid treatment plan and in doing so help reduce the incidence of antibiotic resistance.
You can email us at firstname.lastname@example.org for more information.
Test&Treat INC - 418 LeGrand Blvd, Greenville SC, 29607 USA
Test&Treat Ltd - Unit 1.3 Lanwades Business Park, Kentford CB8 7PN, UK
UK: 01638 501974
Copyright: 2020 test&treat